In acute promyelocytic leukemia (APL), the fusion protein PML/RARα downregulates the expression of CDKN2D by suppressing its promoter activity, which in turn affects leukemia cell proliferation and differentiation [46]. Here, RARA is linked to acute promyelocytic leukemia.